Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

FDA Panel To Ponder Approval Factors For OTC Infectious Disease Diagnostics

This article was originally published in The Gray Sheet

Executive Summary

FDA plans to hold an advisory panel meeting in mid-August to discuss the potential risks and benefits of clearing or approving over-the-counter infectious disease tests.

Advertisement

Related Content

OraSure Preps October Launch Of First-Ever In-Home HIV Test

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register